Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium
Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Jolanta Kupryjańczyk(Cedars-Sinai Medical Center), Yi Lu(Karolinska Institutet), Jonathan P. Tyrer(University of Cambridge), Peter A. Fasching(Universitätsklinikum Erlangen), Honglin Song(University of Cambridge), Jenny Chang‐Claude(Universität Hamburg), Jan Lubiński(Tumour Institute of Tuscany), Douglas A. Levine(New York University), Ian Campbell(The University of Sydney), Alice S. Whittemore(Cancer Registry of Norway), Matthias W. Beckmann(Universitätsklinikum Erlangen), Arif B. Ekici(University Medical Center Groningen), Leon F.A.G. Massuger(Radboud University Nijmegen), Lambertus A. Kiemeney(Radboud University Nijmegen), Daniel O. Stram, Simon A. Gayther(The University of Texas Health Science Center at Houston), Aleksandra Gentry‐Maharaj(UCL Australia), Susan J. Ramus(Cancer Institute of New South Wales), Anna Jakubowska(Pomeranian Medical University), Ignace Vergote(KU Leuven), Nicolas Wentzensen(National Cancer Institute), Valerie McGuire(Cargill (Netherlands)), Malcolm C. Pike(Kettering University), Louise A. Brinton(National Cancer Institute), Argyrios Ziogas(University of Copenhagen), Anna H. Wu(University of Southern California), Siddhartha Kar(University of Cambridge), Jennifer A. Doherty(Cancer Prevention Institute of California), Francesmary Modugno(University of Pittsburgh), Valerie Rhenius(University of Cambridge), Hoda Anton‐Culver(University of California, Irvine), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Usha Menon(University of South Florida), Els Van Nieuwenhuysen, Alexander Hein, Cezary Cybulski(International Hereditary Cancer Center), Jacek Gronwald(International Hereditary Cancer Center), Bo Gao(Blacktown & Mount Druitt Hospital), Celeste Leigh Pearce(University of Southern California), Jonathan Beesley(QIMR Berghofer Medical Research Institute), Mary Anne Rossing(Fred Hutch Cancer Center), Rebecca Sutphen(University of South Florida), Sandrina Lambrechts(Dartmouth College), Kirsten B. Moysich(Roswell Park Comprehensive Cancer Center), Joseph H. Rothstein(University of Washington Medical Center), Roberta B. Ness(The University of Texas Health Science Center at Houston), Jolanta Lissowska, Diana Eccles(Princess Anne Hospital), Weiva Sieh(The University of Texas MD Anderson Cancer Center)
Cited by 38
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k